Clinical trial
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 · HRA Pharma, Industry · Completed
Key facts
| NCT number | NCT00411684 |
|---|---|
| Title | Safety and Efficacy of CDB-2914 for Emergency Contraception |
| Official title | A Prospective, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of CDB-2914 as Emergency Contraception When Taken Between 48 Hours and 120 Hours of Unprotected Sex |
| Lead sponsor | HRA Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Emergency Contraception |
| Intervention type | Drug |
| Interventions | CDB-2914 |
| Enrollment | 1,623 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 8, 2008 |
| Completion | Jun 5, 2009 |
| First posted | Dec 14, 2006 |
| Last update posted | Sep 21, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: